Literature DB >> 20811517

Trace elements and vitamin E status in Nigerian patients with prostate cancer.

O A Adaramoye1, O Akinloye, I K Olatunji.   

Abstract

BACKGROUND: Prostate cancer is the most common type of cancer among men.
OBJECTIVES: To investigate the trace elements (Se, Zn, Cu and Cd) and vitamin E status of some Nigerian prostate cancer (PCa) patients relative to their prostate-specific antigen (PSA) values.
METHODS: Prostate cancer patients were assigned into groups 1, 2 and 3 with PSA of 5-10 ng/ml, 11-20 ng/ml and > 20 ng/ml, respectively.
RESULTS: The results showed that the levels of whole blood superoxide dismutase (SOD) and serum Se and Zn were significantly lower (p< 0.05) in the PCa patients. Specifically, levels of SOD, Se and Zn decreased by 67%, 30% and 35%; 70%, 52% and 41%; 81%, 58% and 47%, in subjects with PSA of 5-10 ng/ml, 11-20 ng/ml and > 20 ng/ml, respectively. There were no significant differences (p> 0.05) in levels of Cu and Cd. Serum Cu/ Zn ratio were significantly higher in PCa patients. The Cu/ Zn ratios were 1: 1.2: 1.3 for subjects in groups 1, 2 and 3, respectively. Vitamin E levels in PCa patients were significantly lower and followed the order; normal > PSA (5-10) > PSA (11-20) > PSA (> 20).
CONCLUSIONS: Deficiency of vitamin E, Zn and Se may be risk factors for development of PCa.

Entities:  

Keywords:  Lipid peroxidation; PSA values; Prostate cancer; Trace elements; Vitamin E

Mesh:

Substances:

Year:  2010        PMID: 20811517      PMCID: PMC2895796     

Source DB:  PubMed          Journal:  Afr Health Sci        ISSN: 1680-6905            Impact factor:   0.927


  36 in total

1.  dl-alpha-tocopherol induces apoptosis in erythroleukemia, prostate, and breast cancer cells.

Authors:  G Sigounas; A Anagnostou; M Steiner
Journal:  Nutr Cancer       Date:  1997       Impact factor: 2.900

2.  Blood levels of natural antioxidants in gastric and colorectal precancerous lesions and cancers in Slovakia.

Authors:  I Beno; J Klvanová; T Magálová; A Brtková
Journal:  Neoplasma       Date:  2000       Impact factor: 2.575

3.  Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: incidence and mortality in a controlled trial.

Authors:  O P Heinonen; D Albanes; J Virtamo; P R Taylor; J K Huttunen; A M Hartman; J Haapakoski; N Malila; M Rautalahti; S Ripatti; H Mäenpää; L Teerenhovi; L Koss; M Virolainen; B K Edwards
Journal:  J Natl Cancer Inst       Date:  1998-03-18       Impact factor: 13.506

4.  Selenium supplementation and secondary prevention of nonmelanoma skin cancer in a randomized trial.

Authors:  Anna J Duffield-Lillico; Elizabeth H Slate; Mary E Reid; Bruce W Turnbull; Patricia A Wilkins; Gerald F Combs; H Kim Park; Earl G Gross; Gloria F Graham; M Suzanne Stratton; James R Marshall; Larry C Clark
Journal:  J Natl Cancer Inst       Date:  2003-10-01       Impact factor: 13.506

5.  The effect of prostate cancer and antiandrogenic therapy on lipid peroxidation and antioxidant systems.

Authors:  Alkan Hacer Iynem; Ayşe Zeynep Alademir; Can Obek; Ali Riza Kural; Dildar Konukoğlu; Tülay Akçay
Journal:  Int Urol Nephrol       Date:  2004       Impact factor: 2.370

6.  Characterization of mammalian selenoproteomes.

Authors:  Gregory V Kryukov; Sergi Castellano; Sergey V Novoselov; Alexey V Lobanov; Omid Zehtab; Roderic Guigó; Vadim N Gladyshev
Journal:  Science       Date:  2003-05-30       Impact factor: 47.728

7.  Prostate specific antigen expression is down-regulated by selenium through disruption of androgen receptor signaling.

Authors:  Yan Dong; Soo Ok Lee; Haitao Zhang; James Marshall; Allen C Gao; Clement Ip
Journal:  Cancer Res       Date:  2004-01-01       Impact factor: 12.701

8.  The thioredoxin-thioredoxin reductase system: over-expression in human cancer.

Authors:  David T Lincoln; Eman M Ali Emadi; Kathryn F Tonissen; Frank M Clarke
Journal:  Anticancer Res       Date:  2003 May-Jun       Impact factor: 2.480

9.  Diverse effects of methylseleninic acid on the transcriptional program of human prostate cancer cells.

Authors:  Hongjuan Zhao; Michael L Whitfield; Tong Xu; David Botstein; James D Brooks
Journal:  Mol Biol Cell       Date:  2003-11-14       Impact factor: 4.138

10.  RRR-alpha-tocopheryl succinate inhibits human prostate cancer cell invasiveness.

Authors:  Min Zhang; Saleh Altuwaijri; Shuyuan Yeh
Journal:  Oncogene       Date:  2004-04-15       Impact factor: 9.867

View more
  1 in total

Review 1.  The Burden of Cancer, Government Strategic Policies, and Challenges in Pakistan: A Comprehensive Review.

Authors:  Anwar Ali; Muhammad Faisal Manzoor; Nazir Ahmad; Rana Muhammad Aadil; Hong Qin; Rabia Siddique; Sakhawat Riaz; Arslan Ahmad; Sameh A Korma; Waseem Khalid; Liu Aizhong
Journal:  Front Nutr       Date:  2022-07-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.